Collaborative Research program in Biomedical Innovation Law

The overall aim and ambition of CeBIL is to contribute to the translation of groundbreaking biomedical research into safe, effective, affordable and accessible therapies by analyzing the most significant legal challenges to pharmaceutical innovation and public health from a holistic cross-disciplinary perspective.

Bacteria

CeBIL addresses fundamental legal challenges in the pharma and life sciences taking into account the eco-system of bio-pharmaceutical innovation and health-care. The Research Program’s unique focus on biomedical innovation law that cuts across various legal disciplines and brings in interdisciplinary, industry and policy perspectives provides an important contribution to the future of the bio-pharmaceutical innovation system. During the first 5 years, CeBIL focuses on Innovation Inefficiencies on the Life Science Frontiers through 5 concrete interrelated studies complemented by a 6th synergy study.

Table of study six: synergy and policy solutions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Researchers

Internal Researchers

Name Title Image
Belay, Dagim Postdoc Billede af Belay, Dagim
Bostyn, Sven Jean R Associate professor Billede af Bostyn, Sven Jean R
Corrales Compagnucci, Marcelo Associate professor Billede af Corrales Compagnucci, Marcelo
Floryan, Leonard PhD student Billede af Floryan, Leonard
Gunnarsdóttir, Hrefna Dögg PhD student Billede af Gunnarsdóttir, Hrefna Dögg
Minssen, Timo Director of centre, professor Billede af Minssen, Timo
Wested, Jakob Postdoc Billede af Wested, Jakob
Yu, Helen Associate professor Billede af Yu, Helen

External Researchers

Funding

Novo Nordisk Foundation

CeBIL is supported by a grant of DKK 35 million from the Novo Nordisk Foundation

Project: Collaborative Research Program in Biomedical Innovation Law

(NNF17SA0027784)

Period: 2018-2023

Contact

Timo MinssenPI Director of centre, professor
Timo Minssen

South Campus,
Building: 6B.3.09A
DK-2300 Copenhagen S
Phone: +46 70 86 07 517
E-mail: timo.minssen@jur.ku.dk

Core partners

University of Copenhagen
University of Cambridge
Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, Harvard Law School
PORTAL - Program on Regulation, Therapeutics and Law, Harvard Medical School and Brigham & Women’s Hospital
University of Michigan Law School